HERON THERAPEUTICS INC
HRTXLatest QuantConomy context for HRTX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
HERON THERAPEUTICS INC
QuantConomy has a structured record for HRTX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- HRTX
- Name
- HERON THERAPEUTICS INC
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq openfigi
Recent signals for HRTX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| dry up | neutral | 19 | Jul 10, 05:25 PM | HRTX volume dry-up: 21% of expected volume for Friday 17:00 UTC, price flat 0.15% (strength 19) |
| dry up | neutral | 48 | Jul 10, 04:16 PM | HRTX volume dry-up: 9% of expected volume for Friday 16:00 UTC, price flat 0.35% (strength 48) |
| major spike | neutral | 70 | Jul 10, 03:40 PM | HRTX major volume spike: 1083% of expected volume for Friday 15:00 UTC, price flat 0.20% (strength 70) |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| HRTX | NASDAQ | alpaca | Heron Therapeutics, Inc. Common Stock |
| HRTX | NASDAQ | alphavantage | Heron Therapeutics Inc |
| HRTX | NASDAQ | fmp | Heron Therapeutics, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Duarte Ira | EVP, Chief Financial Officer | exercise | 12,500 | — | — | 4 on EDGAR |
| Jun 6, 2026 | Forbes William P | EVP, Chief Development Officer | exercise | 12,500 | — | — | 4 on EDGAR |
| May 6, 2026 | Hensley Mark Earl | Chief Operating Officer | exercise | 125,000 | — | — | 4 on EDGAR |
| Apr 30, 2026 | Hensley Mark Earl | Chief Operating Officer | exercise | 11,770 | — | — | 4 on EDGAR |
| Apr 30, 2026 | Duarte Ira | EVP, Chief Financial Officer | exercise | 11,694 | — | — | 4 on EDGAR |
| Apr 30, 2026 | Collard Craig A | Chief Executive Officer | exercise | 34,789 | — | — | 4 on EDGAR |
| Apr 30, 2026 | Forbes William P | EVP, Chief Development Officer | exercise | 11,694 | — | — | 4 on EDGAR |
| Apr 19, 2026 | Duarte Ira | EVP, Chief Financial Officer | exercise | 3,874 | — | — | 4 on EDGAR |
| Apr 19, 2026 | Forbes William P | EVP, Chief Development Officer | exercise | 3,874 | — | — | 4 on EDGAR |
| Apr 19, 2026 | Collard Craig A | Chief Executive Officer | exercise | 13,797 | — | — | 4 on EDGAR |
| Apr 3, 2026 | Collard Craig A | Chief Executive Officer | exercise | 62,500 | — | — | 4 on EDGAR |
| Jan 31, 2026 | Forbes William P | EVP, Chief Development Officer | exercise | 11,695 | — | — | 4 on EDGAR |
| Jan 31, 2026 | Duarte Ira | EVP, Chief Financial Officer | exercise | 11,695 | — | — | 4 on EDGAR |
| Jan 31, 2026 | Collard Craig A | Chief Executive Officer | exercise | 34,789 | — | — | 4 on EDGAR |
| Jan 30, 2026 | Kaseta Michael | Director | grant | 53,960 | $0.00 | $0 | 4 on EDGAR |
| Jan 30, 2026 | Christian Waage | Director | grant | 53,960 | $0.00 | $0 | 4 on EDGAR |
| Jan 30, 2026 | Johnson Craig A | Director | grant | 53,960 | $0.00 | $0 | 4 on EDGAR |
| Jan 30, 2026 | Hensley Mark Earl | Chief Operating Officer | grant | 188,315 | — | — | 4 on EDGAR |
| Jan 30, 2026 | Morgan Adam | Insider | grant | 53,960 | $0.00 | $0 | 4 on EDGAR |
| Jan 30, 2026 | Collard Craig A | Chief Executive Officer | grant | 800,337 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query HRTX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access